Hybrigenics - Stock

Hybrigenics Revenue 2024

Hybrigenics Revenue

0 EUR

Ticker

ALHYG.PA

ISIN

FR0004153930

WKN

A0M9ZU

In 2024, Hybrigenics's sales reached 0 EUR, a 0% difference from the -100 EUR sales recorded in the previous year.

The Hybrigenics Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2021--
2020-0-233680,00
20190.2399,47
20180.0859,74
2017--
20161.4996,31
20151.16-7,48
20145.2724,94
20134.9883,50
20124.0923,96
20116.5793,76
20104.5484,58
20094.7984,13
20084.1784,17
20073.3779,53
20063.687,22
20053.6184,21
20042.2874,12
20032.3178,79

Hybrigenics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Hybrigenics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Hybrigenics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Hybrigenics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Hybrigenics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Hybrigenics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Hybrigenics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Hybrigenics’s growth potential.

Hybrigenics Revenue, Profit, and EBIT History

DateHybrigenics RevenueHybrigenics EBITHybrigenics Net Income
20210 undefined-123,300 undefined-69,160 undefined
2020-100 undefined-317,110 undefined-326,680 undefined
2019234,930 undefined-1.36 M undefined-735,510 undefined
201877,000 undefined-7.64 M undefined-7.53 M undefined
20170 undefined-7.38 M undefined-7.96 M undefined
20161.49 M undefined-4.02 M undefined-5.26 M undefined
20151.16 M undefined-5 M undefined-4.38 M undefined
20145.27 M undefined-2.48 M undefined-2.58 M undefined
20134.98 M undefined-2.36 M undefined-1.79 M undefined
20124.09 M undefined-3.72 M undefined-2.45 M undefined
20116.57 M undefined-2.72 M undefined-2.06 M undefined
20104.54 M undefined-4.87 M undefined-4.56 M undefined
20094.79 M undefined-4.92 M undefined-4.19 M undefined
20084.17 M undefined-7.18 M undefined-6.37 M undefined
20073.37 M undefined-6.32 M undefined-6 M undefined
20063.6 M undefined-3.94 M undefined-3.55 M undefined
20053.61 M undefined-4.86 M undefined-5.98 M undefined
20042.28 M undefined-5.09 M undefined-7.42 M undefined
20032.31 M undefined-5.66 M undefined-5.4 M undefined

Hybrigenics stock margins

The Hybrigenics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hybrigenics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hybrigenics.
  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Hybrigenics's sales revenue. A higher gross margin percentage indicates that the Hybrigenics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Hybrigenics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Hybrigenics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Hybrigenics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Hybrigenics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Hybrigenics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Hybrigenics Margin History

Hybrigenics Gross marginHybrigenics Profit marginHybrigenics EBIT marginHybrigenics Profit margin
202199.47 %0 %0 %
202099.47 %317,110 %326,680 %
201999.47 %-579.13 %-313.08 %
201859.74 %-9,919.48 %-9,776.62 %
201799.47 %0 %0 %
201696.31 %-269.64 %-352.35 %
2015-7.48 %-429.58 %-376.18 %
201424.94 %-47.07 %-48.96 %
201383.5 %-47.34 %-35.93 %
201223.96 %-90.95 %-59.9 %
201193.76 %-41.4 %-31.35 %
201084.58 %-107.27 %-100.44 %
200984.13 %-102.71 %-87.47 %
200884.17 %-172.18 %-152.76 %
200779.53 %-187.54 %-178.04 %
200687.22 %-109.44 %-98.61 %
200584.21 %-134.63 %-165.65 %
200474.12 %-223.25 %-325.44 %
200378.79 %-245.02 %-233.77 %

Hybrigenics Aktienanalyse

What does Hybrigenics do?

Hybrigenics SA is a French company that was founded in 1997 to develop innovative technologies for the discovery and development of new drugs. The company specializes in the identification of proteins responsible for the development of cancer and other diseases, as well as the development of therapies for these diseases. It is headquartered in Paris and has branches in the United States and Japan. Hybrigenics has become a leading provider of protein research technologies since its founding, employing approximately 50 employees including scientists, engineers, and technicians. The company's business model is based on developing innovative technologies for drug discovery and development. It conducts research and development in the field of protein research, particularly protein interaction analysis. The company aims to better understand the mechanism of action of proteins involved in disease development in order to develop targeted therapies. Hybrigenics collaborates closely with its customers to develop tailored solutions for their specific research needs. It provides a range of products and services including proteomic services, screening tools, data analysis software, and platform technologies. The company is divided into different divisions, including proteomic services, screening tools, data analysis software, and platform technologies. Some of the key divisions include proteomic services, which offer customers proteomic services based on decades of experience in protein research and analysis. These services allow customers to identify new proteins involved in specific diseases and also provide protein interaction analysis services to better understand the mechanism of action of disease proteins. Hybrigenics offers screening tools that allow customers to quickly and easily investigate and compare different proteins. These tools are particularly useful for identifying proteins that can serve as indicators for specific diseases. The company also offers data analysis software that enables customers to quickly and accurately evaluate the results of their protein research. This software uses algorithms and artificial intelligence to analyze data and identify patterns. Hybrigenics has also developed a range of platform technologies to help customers optimize their protein research. These technologies include the yeast two-hybrid assay, which can be used to study protein interactions, as well as various technologies for protein expression and purification. Hybrigenics offers a variety of products tailored to its different divisions. Some of the key products include the PIII-Toolbox, a comprehensive platform technology for protein research that allows for fast and efficient identification of protein-protein interactions, HybriScreen Plus, a screening tool that helps customers quickly and easily investigate and compare different proteins, and the yeast two-hybrid assay, a platform technology for studying protein interactions to better understand the mechanism of action of disease proteins. Hybrigenics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Hybrigenics's Sales Figures

The sales figures of Hybrigenics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Hybrigenics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Hybrigenics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Hybrigenics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Hybrigenics Stock

How much revenue did Hybrigenics generate this year?

Hybrigenics has achieved a revenue of 0 EUR this year.

How much was the turnover of the company Hybrigenics compared to the previous year?

The revenue of Hybrigenics has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Hybrigenics?

The revenue of Hybrigenics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Hybrigenics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Hybrigenics so important for investors?

The revenue of Hybrigenics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Hybrigenics pay?

Over the past 12 months, Hybrigenics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hybrigenics is expected to pay a dividend of 0 EUR.

What is the dividend yield of Hybrigenics?

The current dividend yield of Hybrigenics is .

When does Hybrigenics pay dividends?

Hybrigenics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hybrigenics?

Hybrigenics paid dividends every year for the past 0 years.

What is the dividend of Hybrigenics?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hybrigenics located?

Hybrigenics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hybrigenics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hybrigenics from 6/23/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/23/2024.

When did Hybrigenics pay the last dividend?

The last dividend was paid out on 6/23/2024.

What was the dividend of Hybrigenics in the year 2023?

In the year 2023, Hybrigenics distributed 0 EUR as dividends.

In which currency does Hybrigenics pay out the dividend?

The dividends of Hybrigenics are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Hybrigenics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Hybrigenics

Our stock analysis for Hybrigenics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hybrigenics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.